# OnCo record nct06539182 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06539182/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06539182", "NCT06539182" ;
  schema:name "DZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8)"@en ;
  schema:alternateName "TAI-SHAN8"@en ;
  schema:description "A phase 2 trial of DZD8586 in chronic lymphocytic leukaemia, run by Dizal Pharmaceuticals, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06539182/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06539182> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2024-04-29" ;
  onco:cancers <https://onco.cc/cancers/cll/>, <https://onco.cc/cancers/cll-relapsed/> ;
  onco:drugs <https://onco.cc/drugs/dzd8586/> ;
  onco:companies <https://onco.cc/companies/dizal/> .